Adjuvant chemoradiotherapy prolonged overall survival. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Diseases22

Adenocarcinoma Esophageal Neoplasms Carcinoma, Squamous Cell Rectal Neoplasms Neoplasm Recurrence, Local Head and Neck Neoplasms Lung Neoplasms Nasopharyngeal Neoplasms Carcinoma, Non-Small-Cell Lung Lymphatic Metastasis Breast Neoplasms Neoplasm Metastasis Hypopharyngeal Neoplasms Disease Progression Laryngeal Neoplasms Pancreatic Neoplasms Oropharyngeal Neoplasms Brain Neoplasms Carcinoma Radiation Injuries Recurrence Stomach Neoplasms

Chemicals and Drugs17

Fluorouracil Cisplatin Adjuvants, Immunologic Antineoplastic Agents Deoxycytidine Antimetabolites, Antineoplastic Freund's Adjuvant Carboplatin Tumor Markers, Biological Taxoids Leucovorin Paclitaxel Cyclophosphamide Organoplatinum Compounds Vincristine Doxorubicin Etoposide

Analytical, Diagnostic and Therapeutic Techniques and Equipment36

Chemoradiotherapy, Adjuvant Chemoradiotherapy Radiotherapy, Adjuvant Chemotherapy, Adjuvant Combined Modality Therapy Gastrectomy Treatment Outcome Survival Rate Disease-Free Survival Retrospective Studies Antineoplastic Combined Chemotherapy Protocols Survival Analysis Neoplasm Staging Prognosis Neoadjuvant Therapy Kaplan-Meier Estimate Radiotherapy Dosage Follow-Up Studies Esophagectomy Radiotherapy Dose Fractionation Drug Administration Schedule Proportional Hazards Models Induction Chemotherapy Remission Induction Multivariate Analysis Organ Sparing Treatments Radiotherapy, Conformal Prospective Studies Preoperative Care Salvage Therapy Positron-Emission Tomography Immunohistochemistry Randomized Controlled Trials as Topic Digestive System Surgical Procedures Brachytherapy

Phenomena and Processes2

Cell Survival Time Factors

Disciplines and Occupations1

Immunohistochemistry

Anthropology, Education, Sociology and Social Phenomena1

Information Science2

Survival Rate Radiotherapy, Conformal

Health Care13

Treatment Outcome Survival Rate Disease-Free Survival Retrospective Studies Survival Analysis Kaplan-Meier Estimate Follow-Up Studies Proportional Hazards Models Multivariate Analysis Prospective Studies Preoperative Care Radiation Injuries Randomized Controlled Trials as Topic

Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Information Science Health Care

Chemoradiotherapy, Adjuvant Chemoradiotherapy Radiotherapy, Adjuvant Chemotherapy, Adjuvant Combined Modality Therapy Gastrectomy Fluorouracil Treatment Outcome Adenocarcinoma Survival Rate Disease-Free Survival Retrospective Studies Antineoplastic Combined Chemotherapy Protocols Survival Analysis Neoplasm Staging Cisplatin Prognosis Adjuvants, Immunologic Neoadjuvant Therapy Esophageal Neoplasms Kaplan-Meier Estimate Carcinoma, Squamous Cell Rectal Neoplasms Neoplasm Recurrence, Local Radiotherapy Dosage Head and Neck Neoplasms Follow-Up Studies Esophagectomy Antineoplastic Agents Cell Survival Radiotherapy Lung Neoplasms Deoxycytidine Dose Fractionation Drug Administration Schedule Antimetabolites, Antineoplastic Freund's Adjuvant Proportional Hazards Models Nasopharyngeal Neoplasms Induction Chemotherapy Time Factors Carcinoma, Non-Small-Cell Lung Lymphatic Metastasis Carboplatin Survival Tumor Markers, Biological Remission Induction Breast Neoplasms Neoplasm Metastasis Taxoids Multivariate Analysis Leucovorin Paclitaxel Cyclophosphamide Organoplatinum Compounds Hypopharyngeal Neoplasms Vincristine Organ Sparing Treatments Doxorubicin Disease Progression Laryngeal Neoplasms Pancreatic Neoplasms Oropharyngeal Neoplasms Radiotherapy, Conformal Prospective Studies Preoperative Care Salvage Therapy Brain Neoplasms Carcinoma Etoposide Positron-Emission Tomography Immunohistochemistry Radiation Injuries Randomized Controlled Trials as Topic Recurrence Stomach Neoplasms Digestive System Surgical Procedures Brachytherapy

No FAQ available that match "adjuvant chemoradiotherapy prolonged overall survival"